ASX small caps leading the fight against cancer
* TV
SHARE
StockTalk is a * video series featuring a roundtable of experts discussing a new investment topic each week. In this edition, host Dr Nigel Finch discusses ASX health and biotechnology companies focused on fighting cancer.
Populating the expert panel this week is Tim Boreham, health & biotech journalist, Leslie Chong, CEO & managing director of Imugene (ASX:IMU) and Steven Yatomi-Clarke, CEO & managing director of Prescient Therapeutics (ASX
TX).
The group discusses a range of topics, including appraising biotech stocks and valuing milestones, key development stages for oncology treatments, the importance of banking and M&A skills on biotech boards, key trends and investment hotspots and much more.
ASX small caps leading the fight against cancerStockhead TV2...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
-0.002(3.57%) |
Mkt cap ! $401.6M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.4¢ | $1.182M | 21.47M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 3441484 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 574188 | 6 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |